EUCTR2005-004504-36-IT进行中（未招募）1 期
A multicenter, randomized, double blind, comparative study to evaluate the safety, tolerability, and efficacy of 2 dosing regimens of caspofungin in the treatment of invasive candidiasis in adults
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A double blind, randomised, multicenter, comparative study of escitalopram and duloxetine in outpatients with Major Depressive DissorderMajor Depressive DisorderEUCTR2004-005069-39-ESH. Lundbeck A/S260
进行中（未招募）
不适用
A double-blind, randomised, multicenter, comparativestudy of escitalopram and duloxetine in outpatients withMajor Depressive DisorderEUCTR2004-005069-39-DEH. Lundbeck A/S260
进行中（未招募）
1 期
A double-blind, randomised, multicenter, comparativestudy of escitalopram and duloxetine in outpatients withMajor Depressive DisorderMajor depressive disorderEUCTR2004-005069-39-SEH. Lundbeck A/S260
进行中（未招募）
1 期
A double-blind, randomised, multicenter, comparative study of escitalopram and duloxetine in outpatients with Major Depressive DisorderMajor depressive disorderEUCTR2004-005069-39-CZH.Lundbeck A/S260
进行中（未招募）
1 期
A double-blind, randomised, multicenter, comparative study of escitalopram and duloxetine in outpatients with Major Depressive DisorderMajor depressive disorderEUCTR2004-005069-39-GBH. Lundbeck A/S260